SugarVita: a Digital Board Game
Launched by MAXIMA MEDICAL CENTER · Apr 26, 2024
Trial Information
Current as of August 27, 2025
Recruiting
Keywords
ClinConnect Summary
The SugarVita trial is studying a new digital board game designed to help people with Type 2 Diabetes manage their condition better. This fun mobile game allows players to step into the shoes of someone living with diabetes, making choices about food, exercise, and medication throughout a typical day. By playing SugarVita, participants can learn how to keep their blood sugar levels in check and earn points for making healthy decisions. The game is designed for anyone over 18 who has been diagnosed with Type 2 Diabetes and meets certain health criteria, such as having a specific level of blood sugar and being above a certain weight.
If you decide to join the trial, you can expect to play the game on your smartphone or tablet, either alone or with family and friends. The goal is to make diabetes management more engaging and enjoyable, as well as to help participants gain more control over their health. It's important to note that this trial is not open to pregnant or breastfeeding women, or those with certain cancers. Overall, SugarVita aims to provide a creative way for people to learn about their condition while having fun!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Informed consent obtained before trial related activities
- • Diagnosed with T2DM
- • HbA1c levels \> 64 mmol/mol (before start of study)
- • BMI \> 25 kg/m2
- • Age above 18 years
- • Patient's language skills are sufficient for participation
- • Subject has a smartphone or tablet and is willing to install the needed application on it
- Exclusion Criteria:
- • Pregnancy or breastfeeding women
- • Malignancy except basal and squamous cell skin cancer
About Maxima Medical Center
Maxima Medical Center is a leading healthcare institution dedicated to advancing medical knowledge and improving patient care through innovative clinical research. With a commitment to excellence, the center conducts a diverse range of clinical trials across various therapeutic areas, collaborating with healthcare professionals and researchers to facilitate the development of new treatments and therapies. Maxima Medical Center prioritizes patient safety and ethical standards, ensuring that all clinical studies adhere to rigorous regulatory requirements. By fostering a culture of collaboration and innovation, the center aims to contribute significantly to the medical community and enhance the quality of life for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Eindhoven, Noord Brabant, Netherlands
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported